Addiction Psychiatry Division Will Participate in Consortium to Develop New Treatment Tools for Addiction
Yale School of Medicine’s Division of Addiction Psychiatry will participate in a consortium funded by a multimillion-dollar federal grant that will attempt to develop new treatment tools for addiction.
$15M NIDA Grant Awarded to Serena Spudich, Mark Gerstein, and Yuval Kluger
Principal Investigators Serena Spudich, MD, MA (Neurology), Mark Gerstein, PhD (Molecular Biophysics and Biochemistry), and Yuval Kluger, PhD (Pathology) were recently awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to establish a Data Center to coordinate, analyze, and make accessible single-cell and other molecular data sets generated by Single-Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects.
WHRY Funds Studies on Stroke, Endometrial Cancer, and Addiction to Opioids
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
Yale Scientists Awarded $8.4M Grant to Develop Treatments for Women With Problem Drinking
Yale Department of Psychiatry scientists have been awarded a five-year, $8.4 million federal grant to establish a new research center at Yale that will develop treatments to help women with problem drinking.
Teen vaping is bad. Nicotine makes it worse, says researcher
Companies that make vaping liquids must now comply with a U.S. Food and Drug Administration policy released last month banning vape liquids that taste like anything but tobacco or menthol. But vaping still delivers something highly appealing and addictive: nicotine. And researchers are just beginning to study the drug’s long-term impact on the developing brain.Source: Science Mag
School of Nursing Lecture Presentation on Feb. 12: "Women, HIV, and Opiate Use Disorder: Bringing Healing to the Center of Care: An Integrated Trauma-informed Behavioral Health Approach"
This lecture, by Rosalind de Lisser, MS, FNP-BC, PMHNP-BC, will be presented at Yale School of Nursing, 400 West Campus Drive, Orange, CT, and made available by Livestream.
Ending Stigma, Saving Lives: Yale Doctors Take on Opioid Addiction
On the lapel of her blazer, Dr. Gail D’Onofrio wears a button bearing one word with a line through it: stigma. D’Onofrio, who chairs Yale’s Department of Emergency Medicine, works to improve outcomes for people with opioid use disorder, and she’s on a crusade against stigma for a simple reason: social fear hinders treatment.
Are Benzodiazepines the New Opioids?
Yale addiction specialists believe the primary care system can play a key role in preventing another medication epidemic. David A. Fiellin, MD, worries that otherwise, the trajectory of benzodiazepine prescriptions might lead to a situation that resembles the opioid crisis.Source: Yale Medicine
Yale Investigators' Lead Grant Awarded as Part of the NIH HEAL Initiative on Opioids
Dr. Gail D’Onofrio, Professor of Emergency Medicine and Public Health and Dr. David Fiellin, Professor of Medicine, Emergency Medicine and Public Health are lead investigators in a $25.5 Million study being conducted by the National Drug Abuse Treatment Clinical Trials Network’s New England Consortium Node.
Yale Researchers Awarded Grant to Study Smoking Treatment in People With HIV
Drs. E. Jennifer Edelman and Steven L. Bernstein received a grant award to address tobacco smoking addiction among people with HIV. The National Cancer Institute grant, totaling more than $3 million, supports a five-year research project.
More Vaping-Related Dangers?
According to a recent Yale study, inhaling vapor from flavored e-cigarette liquid exposes users to previously undetected chemical byproducts called acetals. As a result of the study, the authors hope the FDA will begin to study the short- and long-term effects of inhaled acetals.Source: Yale Medicine